Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-12.81	25.57	29.33
Graham Fair Price	17.21	12.41	10.59
PEG	-48.78	0.35	-0.68
Price/Book	-0.65	2.08	2.09
Price/Cash Flow	-5.82	34.15	36.26
Prices/Earnings	-22.75	11.90	15.40
Price/Sales	10.65	4.84	4.38
Price/FCF	-5.82	34.15	36.26
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	63.87	0.38	0.23
Operating Margin	-20.83	0.10	0.13
ROA	33.36	0.02	0.01
ROE	0.03	0.04	28.61
ROIC	0.03	0.04	50.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.57	1.10	-48.07
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.04	-0.27	-556.24
EPS QOQ	-0.23	0.34	50.81
FCF QOQ	-0.05	0.09	96.53
Revenue QOQ	0.03	-0.07	144.57
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	10.85	15.08	39.02
Days Sales Outstanding (DSO)	47.51	38.02	-19.97
Inventory Turnover	8.30	5.97	-28.07
Debt/Capitalization	0.26	0.18	-29.83
Quick Ratio	0.47	0.51	8.07
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.12	12.52	3.35
Cash	1.51	2.48	63.66
Capex	-0.13	-0.09	35.85
Free Cash Flow	0.70	0.76	9.03
Revenue	5.79	5.37	-7.20
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.66	0.72	7.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.99	0.90	-81.93
Naive Interpretation	Member

06 - Financial Health · Bad

Rating